Survey: 2012 9th Annual Biopharmaceutical Manufacturing Survey - BioPlan Associates, Inc
Contributor:
Pharma IQ Surveys
Posted: 12/14/2011 12:00:00 AM EST | 1
Posted: 12/14/2011 12:00:00 AM EST | 1
|
Participate in the bio-industry's most in-depth, global study: 9th Annual Biopharmaceutical Manufacturing Report and Survey.
Your input is more important than ever, as we benchmark global and regional trends affecting our industry. You will receive a FREE summary of the results of this important global study. AND for each completed survey we'll donate $10 (up to $10,000) to global health charities.
Takes between 10-25 minutes, depending on your areas of expertise.
Brought to you by BioPlan Associates
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
-
Predictive Toxicology becomes More Important as R&D Costs Rise -
The Global Next Generation Sequencing Applications Market -
Clinical Trial Outsourcing is a Balancing Act for Pharmaceutical Companies -
Will Clinical Trial Activity in Nordic Region Increase? -
Using Industry Spending Data to Develop Strategic Marketing -
The Global Electronic Laboratory Notebooks Forecast 2012 -
FDA 510(k) Submissions for Obtaining FDA Approval (Clearance) -
Clinically Relevant Drug Transporters: What Progress is to be Expected in 2012? -
Top Trends in Laboratory Informatics -
Pressures of Software for Medical Devices
* = required.
Not a member yet? Sign up
Events of Interest
-
Global Pharmaceutical and Bio Contract Manufacturing (GPCM and GBCM)
Chelsea Football Club, London, UK
June 26- 27, 2012 -
Disposable Solutions for Biomanufacturing Asia Pacific 2012
Renaissance Shanghai Pudong Hotel, China
June 21- 21, 2012 -
Outsourcing: Challenging the Project Management System at Your Organisation
July 19, 2011
Register Now -
5th Annual Bio/Pharmaceutical Cold Chain Management Asia
Singapore Expo
May 28- 30, 2012
You Might Also Like
-
Single Use Technologies Changing the Biomanufacturing Landscape
During the past six years, single use systems and devices have emerged as a key change agent in the... Read more
Eric Langer
-
Jan-Gunnar Gustafsson, VP of Process Development and Manufacturing, Baau Therapeutics Speaks to Pharma IQ
Jan-Gunnar Gustafsson Vice President, Process Development and Manufacturing, Baau Therapeutics
-
Managing Quality Relationships with CMOs is Critical for Success
In this Pharma IQ podcast, Diane Petitti, Vice President, Quality at Amylin Pharmaceuticals, speaks to
Pharma IQ
-
Single Use Bioreactors Lead in New Use and Market Penetration
Single use technologies are strong change agents in biopharma manufacturing. Disposable devices emerge... Read more
Eric Langer







Replies (0)
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!